Novo Nordisk A/S Increased Operating Profit In Local Currencies By 15% In 2013
Published: Jan 30, 2014
BAGSVAERD, Denmark, Jan. 30, 2014 (GLOBE NEWSWIRE) -- Sales growth of 12% in local currencies driven by growth in sales of Victoza®, NovoRapid® and Levemir®
Sales increased by 12% in local currencies and by 7% to 83.6 billion in Danish kroner.
Help employers find you! Check out all the jobs and post your resume.